INIS
diseases
100%
liver
100%
failures
100%
patients
83%
nutrition
66%
inflammation
66%
concentration
66%
fibrosis
50%
ileum
50%
pathogenesis
33%
synthesis
33%
cholesterol
33%
data
16%
biopsy
16%
control
16%
comparative evaluations
16%
length
16%
losses
16%
cytokines
16%
pediatrics
16%
Keyphrases
Fibroblast Growth Factor 19 (FGF19)
100%
Intestinal Failure
100%
Intestinal Failure-associated Liver Disease (IFALD)
100%
Parenteral nutrition
44%
Interleukin-6
33%
Ileum
33%
Cholestasis
33%
Tumor Necrosis Factor-α
22%
Cholesterol Synthesis
22%
Portal Inflammation
22%
Inflammatory Cytokines
11%
Fibrosis
11%
Liver Disease
11%
Hepatic Inflammation
11%
Disease States
11%
Liver Biopsy
11%
Hepatic Fibrosis
11%
After Weaning
11%
Partial Loss
11%
Pediatric Onset
11%
Serum IL-6
11%
Total Loss
11%
METAVIR
11%
Inflammation Grade
11%
Fibrosis Stage
11%
Serum TNF-α
11%
Low Serum
11%
Failure Loss
11%
Medicine and Dentistry
Fibroblast Growth Factor 19
100%
Intestinal Failure
100%
Liver Disease
100%
Interleukin 6
44%
Parenteral Nutrition
44%
Tumor Necrosis Factor
33%
Cholestasis
33%
Fibrosis
33%
Ileum
33%
Cholesterol Synthesis
22%
Liver Biopsy
11%
Pediatrics
11%
Inflammatory Cytokine
11%
Diseases
11%
Pharmacology, Toxicology and Pharmaceutical Science
Fibroblast Growth Factor 19
100%
Intestinal Failure
100%
Liver Disease
100%
Interleukin 6
44%
Inflammation
33%
Tumor Necrosis Factor
33%
Cholestasis
33%
Fibrosis
33%
Ileum
33%
Cytokine
11%
Diseases
11%
Immunology and Microbiology
Fibroblast Growth Factor 19
100%
Interleukin 6
44%
Tumor Necrosis Factor Alpha
33%
Ileum
33%
Cholesterol Synthesis
22%
Proinflammatory Cytokine
11%
Biochemistry, Genetics and Molecular Biology
FGF19
100%
Interleukin 6
44%
Tumor Necrosis Factor Alpha
33%
Ileum
33%
Cholesterol Synthesis
22%
Proinflammatory Cytokine
11%
Neuroscience
FGF19
100%
Interleukin 6
44%
Tumor Necrosis Factor Alpha
33%
Ileum
33%
Proinflammatory Cytokine
11%